Romero-Gomez Manuel, Jover Maria, Diaz-Gomez Daniel, de Teran Laura-Collantes, Rodrigo Regina, Camacho Ines, Echevarria Miriam, Felipo Vicente, Bautista Juan-D
Unit for Clinical Management of Digestive Diseases, Hospital Universitario de Valme, ctra Cadiz s/n, 41014 Seville, Spain.
World J Gastroenterol. 2006 Apr 21;12(15):2406-11. doi: 10.3748/wjg.v12.i15.2406.
To assess whether portacaval anastomosis (PCA) in rats affects the protein expression and/or activity of glutaminase in kidneys, intestines and in three brain areas of cortex, basal ganglia and cerebellum and to explain the neurological alterations found in hepatic encephalopathy (HE).
Sixteen male Wistar rats weighing 250-350 g were grouped into sham-operation control (n=8) or portacaval shunt (n=8). Twenty-eight days after the procedure, the animals were sacrificed. The duodenum, kidney and brain were removed, homogenised and mitochondria were isolated. Ammonia was measured in brain and blood. Phosphate-activated glutaminase (PAG) activity was determined by measuring ammonia production following incubation for one hour at 37 celsius degree with O-phthalaldehyde (OPA) and specific activity expressed in units per gram of protein (mukat/g of protein). Protein expression was measured by immunoblotting.
Duodenal and kidney PAG activities together with protein content were significantly higher in PCA group than in control or sham-operated rats (duodenum PAG activity was 976.95+/-268.87 mukat/g of protein in PCA rats vs 429.19+/-126.92mukat/g of protein in sham-operated rats; kidneys PAG activity was 1259.18+/-228.79 mukat/g protein in PCA rats vs 669.67+/-400.8 mukat/g of protein in controls, P<0.05; duodenal protein content: 173% in PCA vs sham-operated rats; in kidneys the content of protein was 152% in PCA vs sham-operated rats). PAG activity and protein expression in PCA rats were higher in cortex and basal ganglia than those in sham-operated rats (cortex: 6646.6+/-1870.4 mukat/g of protein vs 3573.8+/-2037.4 mukat/g of protein in control rats, P<0.01; basal ganglia, PAG activity was 3657.3+/-1469.6 mukat/g of protein in PCA rats vs 2271.2+/-384 mukat/g of protein in sham operated rats, P<0.05; In the cerebellum, the PAG activity was 2471.6+/-701.4 mukat/g of protein vs 1452.9+/-567.8 mukat/g of protein in the PCA and sham rats, respectively, P<0.05; content of protein: cerebral cortex: 162%+/-40% vs 100%+/-26%, P<0.009; and basal ganglia: 140%+/-39% vs 100%+/-14%, P<0.05; but not in cerebellum: 100%+/-25% vs 100%+/-16%, P=ns).
Increased PAG activity in kidney and duodenum could contribute significantly to the hyperammonaemia in PCA rats, animal model of encephalopathy. PAG is increased in non-synaptic mitochondria from the cortex and basal ganglia and could be implicated in the pathogenesis of hepatic encephalopathy. Therefore, PAG could be a possible target for the treatment of HE or liver dysfunction.
评估大鼠门腔静脉吻合术(PCA)是否会影响肾脏、肠道以及大脑皮质、基底神经节和小脑三个脑区中谷氨酰胺酶的蛋白质表达和/或活性,并解释肝性脑病(HE)中出现的神经学改变。
将16只体重250 - 350克的雄性Wistar大鼠分为假手术对照组(n = 8)或门腔静脉分流组(n = 8)。术后28天,处死动物。取出十二指肠、肾脏和大脑,进行匀浆并分离线粒体。测量大脑和血液中的氨含量。通过在37摄氏度下与邻苯二甲醛(OPA)孵育1小时后测量氨生成量来测定磷酸激活谷氨酰胺酶(PAG)活性,以每克蛋白质的单位数(mukat/g蛋白质)表示比活性。通过免疫印迹法测量蛋白质表达。
PCA组十二指肠和肾脏的PAG活性以及蛋白质含量显著高于对照组或假手术大鼠(PCA大鼠十二指肠PAG活性为976.95±268.87 mukat/g蛋白质,假手术大鼠为429.19±126.92mukat/g蛋白质;PCA大鼠肾脏PAG活性为1259.18±228.79 mukat/g蛋白质,对照组为669.67±400.8 mukat/g蛋白质,P<0.05;十二指肠蛋白质含量:PCA组相对于假手术大鼠为173%;肾脏中蛋白质含量PCA组相对于假手术大鼠为152%)。PCA大鼠大脑皮质和基底神经节中的PAG活性和蛋白质表达高于假手术大鼠(大脑皮质:6646.6±1870.4 mukat/g蛋白质,对照组为3573.8±2037.4 mukat/g蛋白质,P<0.01;基底神经节,PCA大鼠PAG活性为3657.3±1469.6 mukat/g蛋白质,假手术大鼠为2271.2±384 mukat/g蛋白质,P<0.05;小脑中,PCA大鼠和假手术大鼠的PAG活性分别为2471.6±701.4 mukat/g蛋白质和1452.9±567.8 mukat/g蛋白质,P<0.05;蛋白质含量:大脑皮质:162%±40% vs 100%±26%,P<0.009;基底神经节:140%±39% vs 100%±14%,P<0.05;但小脑无差异:100%±25% vs 100%±16%,P = 无显著性差异)。
肾脏和十二指肠中PAG活性增加可能对PCA大鼠(肝性脑病动物模型)的高氨血症有显著影响。大脑皮质和基底神经节的非突触线粒体中PAG增加,可能与肝性脑病的发病机制有关。因此,PAG可能是治疗HE或肝功能障碍的一个潜在靶点。